OrbusNeich Medical Group Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
342.00
395.00
172.00
-8.00
56.00
58.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-183.00
-140.00
-37.00
-27.00
21.00
-75.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
198.00
223.00
187.00
153.00
87.00
8.00
Cash Flow from Investing Activities
-97.00
-22.00
-215.00
-40.00
-87.00
-24.00
Cash Flow from Financing Activities
-146.00
7.00
450.00
1,143.00
6.00
13.00
Net Cash Inflow / Outflow
-56.00
208.00
417.00
1,249.00
11.00
-1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-10.00
0.00
-6.00
-6.00
4.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of OrbusNeich Medical Group Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
342.659238001518
350.518726043244
-8.00
-2.24%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-183.432011817181
-59.998778996508
-124.00
-205.73%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
198.780436491522
309.918880036825
-111.00
-35.86%
Cash Flow from Investing Activities
-97.7633008362031
-172.697342081784
75.00
43.39%
Cash Flow from Financing Activities
-146.243098752663
-248.23738563675
102.00
41.09%
Net Cash Inflow / Outflow
-56.0954880446535
-106.897965527878
50.00
47.52%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-10.8695249473087
4.11788215383168
-14.00
-363.96%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -10.99% vs 19.09% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
198.78
223.33
-10.99%






